Medical Articles: 

1. Indman PD.   Hysteroscopic treatment of menorrhagia associated with uterine leiomyomas.  Obstet Gynecol. 1993 May;81(5 ( Pt 1)):716-20. (Entrez Pubmed)
    

2. Ravina JH, Herbreteau D, Ciraru-Vigneron N, Bouret JM, Houdart E, Aymard A, MerlandJJ, “Arterial Embolization to Treat Uterine Myomata”; Lancet September 9, 1995 (Entrez Pubmed)
    

3. Worthington-Kirsch, R.L., Hutchins, F.L.,, and Popky, G.L.  “Uterine Artery Embolization for the Management of Symptomatic Fibroids: Current Experience with 125 Patients and Follow-Up of Up to One Year” (abstract) Radiology 1998; 206(2):575
    
4. Worthington-Kirsch, R.L., Hutchins, F.L., and Popky, G.L. “Uterine Artery Embolization for Management of Symptomatic Fibroids: Mid-Term Results with 175 Patients and Follow-up to 18 Months” (abstract)  Am J Roentgenol 1998; 170(Supp:4):34-35
    
5. Worthington-Kirsch, R.L., Hutchins, F.L., and Popky, G.L. “Uterine Arterial Embolization for the Management of Leiomyomas: Quality of Life Assessment and Clinical Response”,  Radiology 1998; 208:625-629
    
6. Kuhn R, Mitchell P.  “Embolic occlusion of the blood supply to uterine myomas: report of 2 cases”.  Aust NZ J Obstet Gynaecol 1999; 39: 1: 120  (Entrez Pubmed)
    
7. Hutchins, F.L., Worthington-Kirsch, R.L., and Berkowitz, R.P. “Selective Uterine Artery Embolization as Primary Treatment for Symptomatic Leiomyomata Uteri: A Review of 305 Consecutive Cases”,  J Am Assoc Gynecol Laparosc 1999; 6(3):279-284   (Entrez Pubmed)
    
8. Spies JB, Warren E, Mathias S, Walsh SM, Pentecost MJ.  “Measurement of Health-related Quality of Life Before and After Uterine Fibroid Embolization for Symptomatic Leiomyomata.”   J Vasc Interv Radiol 1999;10:1293-1303.
    
9. “Time Course of Pain after Uterine Artery Embolization for Fibroid Disease”; Worthington-Kirsch, R.L., and Koller NE,  The ^2nd International Symposium on Embolization of Uterine Myomata, The Society for Minimally Invasive Therapy, 11^th International Conference, Boston, MA, 1999
    
10. Spies J, Niedzwiecki G, Goodwin S, Patel N, Andrews R, Worthington-Kirsch, R.L., Lippman J, Machan L, Sacks D, Sterling K, Lewis C.  “Training Standards for Physicians Performing Uterine Artery Embolization for Leiomyomata: Consensus Statement Developed by the Task Force of Uterine Artery Embolization and the Standards Division of the Society of Cardiovascular & Interventional Radiology - August 2000”;  J Vasc Interv Radiol 2001; 12:19-21 (Entrez Pubmed)
     
11. Goodwin SC, Bonilla SM, Sacks D, Reed RA, Spies JB, Landow WJ, Worthington-Kirsch, R.L., “Reporting Standards for Uterine Artery Embolization for the Treatment of Uterine Leiomyomata”;  J Vasc Interv Radiol 2001; 12:1011-1020  (Entrez Pubmed)
     
12. Lipman JC, Smith SJ, Spies JB, Siskin GP, Machan LS, Bonn J, Worthington-Kirsch, R.L., Goodwin SC, Hovsepian DM.  “Uterine Fibroid Embolization: Follow-Up”; Techniques in Vascular and Interventional Radiology 2002; 5:44-55
     
13. Spies JB, Coyne K, Guaou Guaou N, et al.  “The UFS-QOL, a New Disease-specific Symptom and Health-related Quality of Life Questionnaire for Leiomyomata.”   Obstet and Gynecol 2002; 99:290-300.  (Entrez Pubmed)
     
14. G. Pron, Mocarski G, Vilos J, Bennett A, Comman L.   Pregnancy after Fibroid Uterine Artery Embolization - The Ontario Uterine Fibroid Embolization (UFE) Trial.   JVIR, February 2003, Vol. 14, No. 2 Part 2: S5.
     
15. Pron, G, Cohen, M, Soucie, J, et al. The Ontario Uterine Fibroid Embolization Trial, Part 1 Baseline patient characteristics, fibroid burden and impact on life. Pub Med,  Fertility and Sterility, January 2003  (Entrez Pubmed)
     
16. Pron, G, Bennett, J, Common, A, et al. The Ontario Uterine Fibroid Embolization Trial Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Pub Med, Fertility and Sterility, January 2003   (Entrez Pubmed)
      
17. Spies JB, Cooper JM, Worthington-Kirsch, R.L., Lipman JC, Mills BB, Benenati JF.  “Outcome of Uterine Embolization and Hysterectomy for Leiomyomas: Results of a Multicenter Study”;  Am J Ob Gyn 2004; 191:22-31 (Entrez Pubmed)
     
18. Andrews RT, Spies JB, Sacks D, Worthington-Kirsch RL, Niedzwiecki GA, Marx MV, Hovsepian DM, Miller DL, Siskin GP, Raabe RD, Goodwin SC, Min RJ, Bonn J, Cardella JF, Patel NH. “Patient Care and Uterine Artery Embolization for Leiomyomata”,  National Guideline Clearinghouse;  J Vasc Interv Radiol 2004 Feb;15(2 Pt 1):115-20.
     
19. Myers E, Goodwin SC, Landow W, Mauro M, Peterson E, Pron G, Spies JB, Worthington-Kirsch, R.L., “Prospective Data Collection of a New Procedure by a Specialty Society: The FIBROID Registry”, Obstet Gynecol 2005; 106:44-51 (Entrez Pubmed)
     
20. Worthington-Kirsch, R.L., Spies JB, Myers E, Mulgund J, Mauro MA, Pron G, Peterson E, Goodwin SC, “The Fibroid Registry for Outcomes Data (FIBROID) for Uterine Artery Embolization”, Obst et Gynecol 2005; 106:52-59 (Entrez Pubmed)
     
21. Spies, JB.;  UFE Five-Year follow-up 182 of 200 patients shows Interventional Radiology procedure is durable:  "Long-Term Data Show Uterine Fibroid Embolization Is Effective Treatment for Uterine Fibroids" - Released April 1, 2005 (SIR)  (Entrez Pubmed)
     
22. "Ovarian Conservation at the Time of Hysterectomy for Benign Disease", William H. Parker, MD, Michael S. Broder, MD, MPH, Zhimei Liu, PhD, Donna Shoupe, MD, Cindy Farquhar, MD, and Jonathan S. Berek, MD, MMSc;  American College of Obstetricians & Gynecologists: Vol. 106, No. 2,  August 2005, 219-226.  (Entrez Pubmed)
     
23. Pron G, Mocarski E, Bennett J, Vilos G, Common A, Vanderburgh L; Ontario UFE Collaborative Group. Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial (555 women).  Obstet Gynecol. 2005 Jan;105(1):67-76.  (Entrez Pubmed)

Note:  Entrez PubMed is a “free” service to locate medical articles, web site URL:  http://www.pubmed.gov.

Uterine Fibroids In Australia
Women's Website Links List
Women of Australia Comments Section